US5258020A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of using expandable polymeric stent with memory
Assignee: Individual
•
Filing: 1992-04-24
•
Granted: 1993-11-02
•
Expires: 2012-04-24
Abstract
Abstract Self-restrained stent for use in a lumen of a vessel of a patient having a body with the vessel therein, comprising a substantially cylindrical member formed of a plastic material having a built-in elastic predetermined diameter and having a memory provided therein of a diameter greater than the predetermined diameter. The plastic is characterized in that it will attempt to assume the greater diameter in its memory upon occurrence of one or more of the following conditions: (a) adsorption of heat by the plastic material; (b) adsorption of a liquid by the plastic material; and (c) a change in the pH in the liquid in which the plastic member is disposed.
Inventors
- 👤 Michael Froix
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 23:02
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/86; A61F2/88; A61F2/90; A61F2/94; A61F2/95; A61F2/958; A61L; A61L31/00; A61L31/04; A61L31/041; A61L31/14; A61L31/146; A61F2210/00; A61F2210/0004; A61F2210/0014; A61F2210/0023; A61F2210/0042; A61F2210/0047; A61F2220/00; A61F2220/0008; A61F2250/00; A61F2250/0058; A61F2250/0067; Y; Y10; Y10S; Y10S623/00; Y10S623/902; Y10S623/903; Y10S623/92; Y10S623/921
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
253 words
A method of using a self-restrained stent in a vessel of a patient, said stent being formed of a biocompatible polymeric composition, the vessel having an interior wall and an inside diameter, forming the polymeric composition in a generally cylindrical member having a predetermined diameter approximately at least as great as the inside diameter of the vessel, said polymeric composition having a memory based on a transition characteristic provided therein of said predetermined diameter, said polymeric composition being characterized in that it will assume said predetermined diameter and move into engagement with the inside wall of the vessel upon activation of said transition characteristic which is achieved by one of the following selected from the group consisting of (a) a melting point of the main chain; (b) a melting point of the side chain; (c) a glass transition temperature; (d) a liquid crystal transition; and (e) a local mode molecular transition; activating the transition characteristic in the polymeric composition, stretching the cylindrical member while the transition characteristic is activated to reduce the diameter of the cylindrical member from the predetermined diameter deactivating the transition characteristic while the cylindrical member remains stretched, keeping the transition characteristic of the cylindrical member inactive until it is ready for use, introducing the stent into the vessel into a predetermined location in the vessel, and activating the transition characteristic while the stent is in the vessel to cause the stent to attempt to return to its predetermined diameter and to frictionally engage the interior wall of the vessel.
Claim 2
Independent Claim
253 words
A method of using a self-restrained stent in a vessel of a patient, said stent being formed of a biocompatible polymeric composition, the vessel having an interior wall and an inside diameter, forming the polymeric composition in a generally cylindrical member having a predetermined diameter approximately at least as great as the inside diameter of the vessel, said polymeric composition having a memory based on a transition characteristic provided therein of said predetermined diameter, said polymeric composition being characterized in that it will assume said predetermined diameter and move into engagement with the inside wall of the vessel upon activation of said transition characteristic which is achieved by one of the following selected from the group consisting of (a) a melting point of the main chain; (b) a melting point of the side chain; (c) a glass transition temperature; (d) a liquid crystal transition; and (e) a local mode molecular transition; activating the transition characteristic in the polymeric composition, stretching the cylindrical member while the transition characteristic is activated to reduce the diameter of the cylindrical member from the predetermined diameter deactivating the transition characteristic while the cylindrical member remains stretched, keeping the transition characteristic of the cylindrical member inactive until it is ready for use, introducing the stent into the vessel into a predetermined location in the vessel, and activating the transition characteristic while the stent is in the vessel to cause the stent to attempt to return to its predetermined diameter and to frictionally engage the interior wall of the vessel.
Claim 3
Dependent Claim
22 words
The method of claim 1, wherein heat is introduced into the stent after said stent is positioned to activate the transition characteristic.
Claim 4
Dependent Claim
26 words
The method as of claim 1 wherein the stent is preheated to adsorb a liquid in the vessel of the patient to activate the transition characteristic.
Claim 5
Dependent Claim
27 words
The method of claim 1 wherein a pH of a liquid is changed in which the stent is disposed to activate the transition characteristic in the stent.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-11-01 | 1997-05-03 | 1997-11-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-11-01 | 2001-05-03 | 2001-11-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-11-01 | 2005-05-03 | 2005-11-02 | $7700.00 | Window Closed / Lapsed |